thalidomide has been researched along with Angioma in 7 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Angioma: A vascular anomaly due to proliferation of blood or lymphatic vessels that forms a tumor-like mass. Vessels in the angioma may or may not be dilated.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hemangiomas are benign neoplasms of the vasculature frequently encountered in children." | 2.47 | Hemangiomas - current therapeutic strategies. ( Mabeta, P; Pepper, MS, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Khurana, A | 1 |
| Savitha, B | 1 |
| Adam, Z | 1 |
| Pour, L | 1 |
| Krejcí, M | 1 |
| Pourová, E | 1 |
| Synek, O | 1 |
| Zahradová, L | 1 |
| Navrátil, M | 1 |
| Mechl, M | 1 |
| Nebeský, T | 1 |
| Neubauer, J | 1 |
| Feit, J | 1 |
| Vokurková, J | 1 |
| Král, Z | 1 |
| Bednarík, O | 1 |
| Slampa, P | 1 |
| Dolezalová, H | 1 |
| Hájek, R | 1 |
| Mayer, J | 1 |
| Mabeta, P | 1 |
| Pepper, MS | 1 |
| Lindner, DJ | 1 |
| Jarvi, K | 1 |
| Roebuck, DJ | 1 |
| Sebire, NJ | 1 |
| Lindley, K | 1 |
| Shah, N | 1 |
| Salomon, J | 1 |
| Curry, JI | 1 |
| Roe, FJ | 1 |
| Walters, MA | 1 |
| Kida, M | 1 |
| Lenz, W | 1 |
3 reviews available for thalidomide and Angioma
| Article | Year |
|---|---|
[Successful treatment of angiomatosis with thalidomide and interferon alpha. A description of five cases and overview of treatment of angiomatosis and proliferating hemangiomas].
Topics: Adult; Aged; Angiogenesis Inhibitors; Angiomatosis; Female; Hemangioma; Humans; Interferon-alpha; Ma | 2010 |
Hemangiomas - current therapeutic strategies.
Topics: Angiogenesis Inhibitors; Bleomycin; Child; Cyclophosphamide; Hemangioma; Humans; Interferons; Neovas | 2011 |
Interferons as antiangiogenic agents.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Syne | 2002 |
4 other studies available for thalidomide and Angioma
| Article | Year |
|---|---|
Refractory angiolymphoid hyperplasia with eosinophilia: Complete resolution with low dose thalidomide.
Topics: Angiolymphoid Hyperplasia with Eosinophilia; Head; Hemangioma; Humans; Rare Diseases; Thalidomide | 2022 |
Successful treatment of extensive infantile hemangiomatosis of the small bowel in a 3-month-old with thalidomide and somatostatin analog.
Topics: Angiogenesis Inhibitors; Female; Hemangioma; Humans; Infant; Intestinal Neoplasms; Somatostatin; Tha | 2008 |
Sensitivity of newborn mice to carcinogenic agents.
Topics: Adenocarcinoma; Adenoma; Animals; Animals, Newborn; Benz(a)Anthracenes; Carcinogens; Carcinoma, Hepa | 1968 |
[Thalidomide embryopathy in Japan].
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Ear; Ectromelia; Female; Fetal Diseases; Finge | 1968 |